Maxigen Biotech, Inc. appears in FDA 510(k) records as the applicant for two substantially equivalent determinations in the supplied collection: FormaAid Collagen Membrane (K260483, decided November 4, 2026) and three HARU water-based lubricant variants (K253989, decided September 3, 2026). Both entries carry the same applicant name and the same Taoyuan address in the filing data. The company's own published material describes a collagen and hyaluronic acid device business founded in December 1998, with research work begun at National Yang-Ming University and headquarters later moved to the Hwa-Ya Technology park in July 2016. [1][2][6]
Dental collagen membrane filings
K260483 covers FormaAid Collagen Membrane under product code NPL, regulation number 872.3930, device class 2, in the Dental advisory committee. The record lists a Traditional clearance type, no third-party review, a Summary statement, and a decision description of Substantially Equivalent. The submission was received February 13, 2026 and decided November 4, 2026. [1]
The company's product page describes FormaAid as a GTR membrane made from purified Type-I collagen extracted from Australian natural bovine tendons, without chemical cross-linking agents, with a stated degradation time of 12 to 18 weeks. Listed applications are guided tissue regeneration, dental implant and oral surgery. A listed catalogue entry is FA-T3040, 30mm x 40mm x 0.3mm, one unit per box. [5]
An earlier dental filing in the numbered sources is K230529 for HealiAid Dental Collagen Wound Dressing, product code OLR, dated October 30, 2023 and received October 31, 2023, with a revised 510(k) summary dated November 22, 2023. [10]
Personal lubricant clearance
K253989 covers three named products: HARU Orgasm by jack herer water based lubricant (WL-OJ), HARU Orgasm water based lubricant (WL-OR) and HARU STEAMY water based lubricant (WL-ST). The record places them under product code NUC, regulation number 884.5300, device class 2, Obstetrics/Gynecology advisory committee, with a Traditional clearance, no third-party review, a Summary statement and a Substantially Equivalent decision. It was received December 12, 2025 and decided September 3, 2026. [2]
Wound dressing clearances
Two SurgiAid Collagen Wound Dressing clearances appear in the numbered sources under product code KGN, each described as unclassified. K223126 was dated July 12, 2023, received July 13, 2023, and cleared October 11, 2023. K242100 was dated and received September 19, 2025 and cleared October 16, 2025, with FDA stating the device is substantially equivalent for the indications for use stated in the enclosure. [8][9]
Company identity and published background
Maxigen Biotech's own investor page states the company was founded in December 1998, set up an incubation center at National Yang-Ming University for collagen research, moved headquarters to Hwa-Ya Technology park in July 2016, and specializes in developing, manufacturing and marketing biomedical and skincare products. That page names TCI Bio, GIH Group, Formosa Biomedical Technology Corp and NuVasive Inc. among major shareholders; these are shareholder references, not verified parent entities. [6]
A company training-center article discusses barrier membranes used in dentistry, describing guided tissue regeneration as use of cell-occlusive barrier membranes to exclude rapid epithelial and fibroblastic downgrowth while allowing repopulation by slower-migrating cells from the periodontal ligament, bone and cementum, and guided bone regeneration as applying the same principles to osseous defects. [3]


